SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: robert heisman who wrote (7236)5/5/1998 8:43:00 PM
From: Robert M. Winn  Read Replies (3) of 8116
 
My personal gut feeling is that all cancer stocks will show good revenues over the next couple of years. Given the hope of a magic bullet being available in two to five years, both patients and doctors are going to be more aggressive in cancer treatments in order to survive until a cure is found.

The study that showed that Quadrament added just one more year to the life of a breast cancer patient means that Quad is a lot more important if someone is to survive until the cure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News